UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Engineered T cell therapies.

Field, AC; Qasim, W; (2015) Engineered T cell therapies. Expert Rev Mol Med , 17 , Article e19. 10.1017/erm.2015.14. Green open access

[thumbnail of erm_1500014_FC_1.pdf]
Preview
Text
erm_1500014_FC_1.pdf

Download (221kB) | Preview

Abstract

Alongside advancements in gene therapy for inherited immune disorders, the need for effective alternative therapeutic options for other conditions has resulted in an expansion in the field of research for T cell gene therapy. T cells are easily obtained and can be induced to divide robustly ex vivo, a characteristic that allows them to be highly permissible to viral vector-mediated introduction of transgenes. Pioneering clinical trials targeting cancers and infectious diseases have provided safety and feasibility data and important information about persistence of engineered cells in vivo. Here, we review clinical experiences with γ-retroviral and lentiviral vectors and consider the potential of integrating transposon-based vectors as well as specific genome editing with designer nucleases in engineered T cell therapies.

Type: Article
Title: Engineered T cell therapies.
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1017/erm.2015.14
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Infection, Immunity and Inflammation Dept
URI: https://discovery.ucl.ac.uk/id/eprint/1471380
Downloads since deposit
534Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item